Mission Statement

The Swiss Rockets’ mission is to deliver outstanding results for patients, investors, and inventors.

Swiss Rockets brings entrepreneurs together with breakthrough technologies and therapies and the best development experts in the field.

Swiss Rockets Entrepreneurship

Swiss Rockets brings entrepreneurs together with breakthrough technologies and the best development experts in the field.

Incubator

Swiss Rockets provides its portfolio companies its broad networks, access to the latest lab technology, instruments and offices, and empowers its founders to work as entrepreneurs enabling a long term benefit from their inventions.

Accelerator

Swiss Rockets provides financial support from the preclinical and clinical stage until marketing approval. Swiss Rockets serves as a funding platform for its portfolio companies.

Expertise

Swiss Rockets supports its portfolio companies with world-leading expertise in cancer medicine, drug development, and various business functions.

Distribution

Swiss Rockets is building a global distribution network and has the mission to ensure that everyone can gain access to best-approved cancer treatments.

We are looking forward to hearing from you!

We invite you to contact us with new product ideas, cooperation opportunities, information for patients, or general comments.

Contact US now!

Our Values and Uniqueness

Patients First

We value all stakeholders but give priority to patients.

We conduct our business with the patients’ well-being in mind. Integrity, honesty, loyalty, and trust form the foundation on which we build our company and future success. All our investments, entrepreneurs, partners, and therapies always put the patients first.

Self-Sufficient Model

Swiss Rockets is designed to be self-sufficient, just like large pharmaceutical groups. Still, with one crucial difference:

We empower people to be entrepreneurs and enable them to benefit long term from their inventions. We are proud to be part of each project in our innovation hub. We want our entrepreneurs to feel motivated to invent the best possible cures for patients around the world.

Self-Sufficient Model

Swiss Rockets is designed to be self-sufficient, just like large pharmaceutical groups. Still, with one crucial difference:

We empower people to be entrepreneurs and enable them to benefit long term from their inventions. We are proud to be part of each project in our innovation hub. We want our entrepreneurs to feel motivated to invent the best possible cures for patients around the world.

Active Involvement

We have a rigorous selection process when choosing new technologies because we invest money, time, and infrastructure into each project.

Companies that decide to work with us are getting more than just an investor; we actively participate in the drug development process and share our entrepreneurial experience, expertise, and infrastructure to ensure that the process from idea to commercialization is as efficient as possible.

Board of Directors

Startup Services

Swiss Rockets provides integrated services through active involvement in the management, drug development, and business development activities of startups. Our experts are ready to help startups achieve their goals.

Scientific

Preclinical and Clinical drug development
API manufacturing
Drug formulation / packaging / labelling
Quality assurance
Quality management

Business

General business support
Legal
Human resources
Intellectual property
Management
Investments
Sales & Marketing
IPO and M&A

Infrastructure

Shared office space in Basel
Shared lab space
Secretarial services
IT infrastructure and services
Presence in media

Education

Business coaching
Collaboration initiatives
Region-specific business etiquette
Entrepreneurial training sessions and workshops
Networking events
Partnership programmes with universities

Our Most Important Stakeholders Are the Patients

All of our projects, investments, and partnerships focus on serving cancer patients and providing for their long-term well-being.

Portfolio

Our portfolio of businesses includes internal projects, spin-off companies, joint ventures with startup companies, and distribution partnerships. A well-diversified portfolio is essential for us to mitigate the risks of individual investments. We focus our efforts on the following industry sectors:

Generic Cancer
Drugs

Most cancer patients rely on the availability of generic oncology medication. We want to make products with exceptional Swiss quality available to patients in countries that currently suffer from supply shortages or high prices.

Targeted Cancer
Therapies

Targeted cancer therapies are drugs that are designed to block the growth and spread of cancer by interfering with specific molecular targets that are involved in the growth, metabolism, progression, and metastasis of cancer cells. Unlike conventional cancer therapies such as chemotherapy, which targets healthy and cancer cells at the same time, targeted therapies are designed to address specific molecular mutations within cancer cells.

Cancer Immuno
Therapies

Cancer immunotherapy stimulates the immune system to fight cancer. We are pursuing new approaches that are designed to cure more patients with fewer side effects.

Personalized
Cancer Therapies

Personalized cancer therapy is a treatment strategy that predicts which patients are more likely to respond to specific cancer therapies. This approach uses specific tumor biomarkers that predict therapy response. We use the sequencing of tumor DNA to reveal genomic alterations and develop perzonalized therapies for treatment-resistant cancers.

Cancer
Prevention

We could prevent a significant number of cancer deaths by avoiding risk factors such as tobacco, overweight, an insufficient diet, physical inactivity, alcohol, sexually transmitted infections, and air pollution. We are developing gene-editing techniques and drugs that may serve as preventative measures.

Innovative MedTech
Devices & Distribution

Drug development is a lengthy and costly process. We have identified several fully approved products that are in the market and can immediately generate returns for our investors while providing us with additional funding to continue our breakthrough drug development efforts.

What Makes Us Different

Creating breakthrough drugs and technologies to fight cancer is a very time-consuming business. We seek investors who, like us, are in it for the long haul.

Specific Expertise

Our team comprises renowned scientists from various fields.

Our management team, our board of directors, and our advisors combine scientific, entrepreneurial, and business excellence from around the world, and we know how to develop companies.

Diversified Research and Development

Our projects cover a broad scope of innovative technologies ranging from the preclinical stage, all the way to already approved and marketed products.

Our portfolio diversification strategy allows us to manage risks better for our investors than many of our competitors.

High-Level Partnerships

Our partnerships at the highest levels of academia, business, and government ensure that we can offer all our stakeholders the best possible chance of success.

Academia provides us with an endless stream of new technologies and potential startups. Business partnerships enable us to market and distribute our products.

Swiss Quality Tradition

Switzerland is well-known as a hub of high-quality products and services.

World-leading companies from the banking, pharmaceutical, watchmaking, and chocolate industries have their origins and headquarters in Switzerland. Swiss Rockets intends to help expand this rich tradition of Swiss Quality products and services.